NetworkNewsBreaks Archive - Page 1953 of 1970

ThursdayNov 10, 2016 2:04 pm

Imprimis Pharmaceuticals, Inc. (IMMY) Inks New Supply Agreement; Shares Climb

Imprimis Pharmaceuticals (NASDAQ: IMMY) is trading 11% higher mid-morning, driven by the company’s product purchase and supply agreement with the specialty pharmacy division of one of the nation's largest pharmacy benefit managers (PBMs) to supply Imprimis' complete formulary of low-cost compounded medications through the PBM's national network of specialty pharmacies. To view the full press release, visit: http://nnw.fm/Y7hHj About Imprimis Pharmaceuticals Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a pharmaceutical company dedicated to producing and dispensing high quality innovative compounded medications in all 50 states. The company's unique business model drives patient access and affordability to many critical medicines. Headquartered in…

ThursdayNov 10, 2016 10:58 am

Galectin Therapeutics, Inc. (GALT) Shares Surge on Positive Interim Data for Lead Candidate GR-MD-02

Shares of Galectin Therapeutics (NASDAQ: GALT) are up more than 30% this morning after delivering positive interim clinical data for its lead candidate GR-MD-02 to treat psoriasis and atopic dermatitis. The company also announced its plans to identify a strategic partnership to further develop the drug candidate for the treatment of serious skin diseases. To view the full press release, visit: http://nnw.fm/d95Ap About Galectin Therapeutics Galectin Therapeutics is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's unique understanding of galectin proteins, which are key mediators of biologic function. Galectin seeks to…

ThursdayNov 10, 2016 10:55 am

Moxian, Inc. (MOXC) Solutions Help Merchants Build Strong Customer Relationships to Keep Competitive Edge

Customer satisfaction is a bedrock for any organization, and the most successful businesses are the ones who dedicate time to cultivate customer-merchant relationships. By listening to consumers, engaging in ongoing communication, rewarding loyalty, and efficiently training employees, businesses are privy to repeat business and word of mouth marketing. While social media creates a wealth of opportunity to build customer relationships, it takes considerable time, knowledge and dedication to pull-off a successful campaign. “Businesses, especially small businesses, are looking to creative outside marketing services to better interact with their consumers. Moxian, Inc. (OTCQB: MOXC) offers exactly such services and more. MOXC…

WednesdayNov 09, 2016 3:39 pm

America Votes Trump; Investors Pounce on Healthcare Stocks

President-elect Donald Trump has long voiced his opposition of ObamaCare and the broader healthcare system, and though his stance on regulating drug prices remains uncertain, drug companies are likely to enjoy lesser scrutiny than they would from a Clinton Administration. In today’s market, here are several healthcare stocks trading higher near market close: Cigna Corp. (NYSE: C) Humana, Inc. (NYSE: HUM) Aetna, Inc. (NYSE: AET) UnitedHealth Group, Inc. (NYSE: UNH) Actinium Pharmaceuticals, Inc. (NYSE: NTM) AmerisourceBergen Corp. (NYSE: ABC) Biogen, Inc. (NASDAQ: BIIB) About NetworkNewsBreaks NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW).…

WednesdayNov 09, 2016 12:19 pm

Will the Trump Train Boost the Construction Industry?

Defying the drop in global markets and futures following Donald Trump’s presidential win, U.S. markets are higher in morning trade. If Trump achieves his vision to bring jobs back to American soil, it could mean big business for companies operating in various aspects of the building and construction trades. In today’s market, here are several construction stocks trading higher: Argan, Inc. (NYSE: AGX) Dycom Industries, Inc. (NYSE: DY) Emcor Group, Inc. (NYSE: EME) Comfort Systems USA, Inc. (NYSE: FIX) Granite Construction, Inc. (NYSE: GVA) Myr Group, Inc. (NYSE: MYRG) NV5 Group, Inc. (NYSE: NVEE) About NetworkNewsBreaks NetworkNewsBreaks (NNB) provide a…

WednesdayNov 09, 2016 10:17 am

Bristol-Myers Squibb Company (BMY), Infinity Pharmaceuticals, Inc. (INFI) Team Up to Evaluate Combination in Solid Tumors Study; Shares Jump

Shares of Bristol-Myers Squibb (NYSE: BMY) and Infinity Pharmaceuticals (NASDAQ: INFI) are higher after the companies announced their clinical trial collaboration to evaluate Bristol-Myers Squibb’s Opdivo in combination with Infinity’s IPI-549 in patients with advanced solid tumors. The dose-escalation portion exploring IPI-549 as a monotherapy in Infinity’s phase 1 study is continuing, and the first dose-escalation cohort studying IPI-549 in combination with Opdivo, a PD-1 immune checkpoint inhibitor, is scheduled to begin this fall. To view the full press release, visit: http://nnw.fm/V4tfN About Infinity Pharmaceuticals, Inc. Infinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with…

TuesdayNov 08, 2016 2:07 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on November 8, 2016

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: GLLK 56.25% - News: Gets green light for exploration work permit in Ontario JMDA 30.77% - News: Partners with lifestyle brand Willie’s Reserve NXGH 24.23% - News: Issues shareholder update ICAD 13.68% - News: Names Richard Christopher as executive VP and CFO PERI 11.22% - News: Posts Q3 results, non-GAAP EPS of $0.12 vs. $0.10 last year CLBS 8.17% - News: Q3 revenues increase 58% to $9.3M LPCN 8.05% - News: Narrows Q3 loss…

TuesdayNov 08, 2016 2:05 pm

Zosano Pharma Corp. (ZSAN) Completes Enrollment in Pivotal Efficacy Trial for Acute Migraine Treatment Candidate; Shares Higher

Shares of Zosano Pharma (NASDAQ: ZSAN) are trending higher in mid-day trade following early news that the company has completed enrollment in its registration-enabling, pivotal efficacy trial (the Zotrip trial) of M207 for the treatment of acute migraine. “The completion of enrollment in the Zotrip study is a major milestone for the Company and bolsters our confidence in the previously announced availability of trial data in the first quarter of 2017,” Konstantinos Alataris, PhD, president and CEO of Zosano Pharma, stated in the news release. “The enrollment pace is also indicative of the urgent need for improved treatment options for…

TuesdayNov 08, 2016 1:39 pm

Great Basin Scientific, Inc. (GBSN) Finishes Trial for Stool Bacterial Pathogens Panel; Shares Lower

Great Basin Scientific (OTCQB: GBSN) this morning reported the completion of its clinical trial of Stool Bacterial Pathogens Panel, a technology designed to detect Salmonella species, Shigella species, Shiga Toxin-producing E. coli species (stx1 and stx 2, O157), and Camphylobacter species (C. jejuni and C. coli). From here Great Basin intends to pursue 510(k) clearance from the Food and Drug Administration (FDA) as well as CE marking. To view the full press release, visit: http://nnw.fm/t5AgC About Great Basin Scientific Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of…

TuesdayNov 08, 2016 10:50 am

ChromaDex Corp. (CDXC) Shares Tick Higher on $5M Credit Facility

ChromaDex (NASDAQ: CDXC) is trading higher this morning after announcing its $5 million credit facility with Bridge Bank. ChromaDex innovates proprietary health, wellness and nutritional ingredients that create science-based solutions to dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products. The company says the credit facility provides the capital needed to expand its proprietary ingredient business. To view the full press release, visit: http://nnw.fm/9joXj About ChromaDex: ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks